Goldline Pharmaceutical Ltd.BSE: GLPL

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

· Issued by Goldline Pharmaceutical Ltd. via BSE India

Filed with BSE · · 2 pages · English

On 6ix: 6ix.com/news/compliances-certificate-under-reg-74-5-of-sebi-dp-regulations-2018-1064

Sub: Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026. Sir / Ma’am, We hereby enclose a certificate under regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026 received from M/s. Bigshare Services Private Limited, Registrar and Share Transfer Agent of our c

Goldline Pharmaceutical Ltd. on 6ix

Earlier from Goldline Pharmaceutical

Later from Goldline Pharmaceutical

All Goldline Pharmaceutical news releases